Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma

This study has been withdrawn prior to enrollment.

(Principal Investigator left institution.)

Sponsor:

Collaborator:

Merck

Information provided by (Responsible Party):

The University of Texas Health Science Center at San Antonio

ClinicalTrials.gov Identifier:

NCT01296659

First received: February 3, 2011

Last updated: July 11, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	August 2011
Primary Completion Date:	August 2011 (Final data collection date for primary outcome measure)